Back to Search
Start Over
Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs.
- Source :
-
PLoS Medicine . 7/9/2019, Vol. 16 Issue 7, p1-10. 10p. 1 Illustration, 1 Chart. - Publication Year :
- 2019
-
Abstract
- Geraint Davies and colleagues discuss the potential for innovative early-phase clinical trial methods and technologies to reduce risk and speed up drug development for tuberculosis. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15491277
- Volume :
- 16
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- PLoS Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 137391253
- Full Text :
- https://doi.org/10.1371/journal.pmed.1002851